Clinical trials
Phase 2/3 ST Elevation Myocardial Infarction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2011 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 3 |
| Recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dexa Medica Group | 1 |
| Federico II University | 1 |
| Iuliu Hatieganu University of Medicine and Pharmacy | 1 |
| KCRI | 1 |
| Ottawa Heart Institute Research Corporation | 1 |
| Oxford University Hospitals NHS Trust | 1 |
| Region Skane | 1 |
| Russian Academy of Medical Sciences | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Suzhou Landing Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ST Elevation Myocardial Infarction | 13 |
| Myocardial Infarction | 3 |
| Thrombosis | 2 |
| Ventricular Remodeling | 2 |
| Acute Coronary Syndrome | 1 |
| Anterior Wall Myocardial Infarction | 1 |
| Cardiovascular Diseases | 1 |
| Coronary Artery Disease | 1 |
| Diabetes Mellitus | 1 |
| Heart Failure | 1 |
Trials
Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.